Nitric oxide produced by cytokine-inducible nitric oxide synthase (iNOS) is thought to be important in the pathogenesis of septic shock To further our understanding of the role of iNOS in normal biology and in a variety of inflammatory disorders, including septic shock, we have used gene targeting to generate a mouse strain that lacks iNOS. Mice lacking iNOS were indistinguishable from wild-type mice in appearance and histology. Upon treatment with lipopolysaccharide and interferon y, peritoneal macrophages from the mutant mice did not produce nitric oxide measured as nitrite in the culture medium. In addition, lysates of these cells did not contain iNOS protein by immunoblot analysis or iNOS enzyme activity. In a Northern analysis of total RNA, no iNOS transcript of the correct size was detected. No increases in serum nitrite plus nitrate levels were observed in homozygous mutant mice treated with a lethal dose of lipopolysaccharide, but the mutant mice exhibited no significant survival advantage over wild-type mice. These results show that lack of iNOS activity does not prevent mortality in this murine model for septic shock
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In biological systems, nitric oxide (NO) is produced via the oxidation of L-arginine by enzymes known as nitric oxide synthases (NOSs). Three NOS isozymes have been described (for recent reviews see refs. 1 and 2). These include constitutively expressed neuronal (3, 4) and endothelial (5, 6) enzymes and a cytokine-induced enzyme found in macrophages (7), hepatocytes (8) , and a variety of other cells (9, 10) . Although the biological functions of these enzymes are not completely understood, neuronal NOS is thought to play a role in neurotransmission (11) , endothelial NOS is involved in regulation ofvascular tone (12, 13) , and inducible NOS (iNOS) is involved in immune defense (14, 15) . The constitutively synthesized neuronal and endothelial enzymes produce small amounts of NO in response to increases in intracellular calcium levels. In contrast, iNOS is synthesized de novo in response to a variety of inflammatory stimuli and produces large amounts of NO over prolonged periods of time (16) . NO produced by iNOS has been shown to be beneficial through its antitumor (17, 18) and antimicrobial (15) activities, but it is also thought to cause tissue damage and contribute to pathology in a variety of inflammatory conditions including rheumatoid arthritis (19, 20) , inflammatory bowel disease (21) , and septic shock (22, 23) .
Septic shock is usually the result of a systemic Gram-negative bacterial infection and is characterized by hypotension and the failure of a number of organ systems, especially the liver, kidney, and heart (24) . The bacterial membrane component, lipopolysaccharide (LPS), induces the production of host inflammatory mediators such as tumor necrosis factor a, interferon y (IFN-,y), and interleukin 1,B, which in turn cause an increase in the expression of iNOS. The large amount of NO produced by iNOS has been hypothesized to contribute to LPS-induced hypotension and mortality.
To better understand the biological function of NO produced by iNOS and to determine whether overproduction of NO plays a crucial role in septic shock, we have used homologous recombination in embryonic stem (ES) cells to disrupt the iNOS gene. From these cells we generated mice that lack iNOS. The mice lacking iNOS were then examined in an LPS-induced model of septic shock.
MATERIALS AND METHODS
Design of Targeting Construct. A library of A bacteriophages carrying fragments derived from a partial Mbo I digest of mouse strain 129 genomic DNA was screened with a fragment of the murine iNOS cDNA (25) that contained the calmodulin-binding domain. A A bacteriophage containing a 14-kb DNA fragment was isolated, from which a 12-kb EcoRI fragment containing the calmodulin-, FMN-, and FAD-binding domains of iNOS was subcloned into pBluescript II SK (Stratagene). The targeting construct, pSPKO-NOS (see Fig.   1 ), consisted of a 9-kb Sph I-EcoRI fragment in which theApa I-Kpn I fragment containing the calmodulin-binding domain was replaced by the neomycin resistance gene from pMClNeo polA (27) . A copy of the herpes simplex virus thymidine kinase gene was introduced into the construct to allow positivenegative selection (28) . Before electroporation, pSPKO-NOS was linearized with Hpa I.
ES Cell Transfection and Selection. The 129-derived ES cell line E14TG2a (29) was cultured on irradiated primary embryonic fibroblast-feeder layers in Dulbecco's modified Eagle medium-H, as described (30) . Electroporation was essentially as described (31) . In 0.8 ml of medium, 3 x 107 ES cells were mixed with 22 ,ug of the linearized pSPKO-NOS targeting construct and electroporated using the Gene Pulser (Bio-Rad) at 230 V and 500 ,LF. Cells were then transferred to 10-cmdiameter feeder plates. Medium was replaced the following day with medium containing G418 (200 ,ug/ml) and ganciclovir (2 ,ug/ml). Drug-resistant colonies were grown in 16-mmdiameter wells and transferred to 35-mm-diameter wells. Subsequently, half of each culture was lysed for PCR analysis. Recombinants were identified by PCR using the primers a and b as illustrated in Fig. 1 (36) . Nitrite in macrophage culture supernatants was measured spectrophotometrically as described (36) Fig. 1 . After homologous recombination, the calmodulin-binding domain of iNOS is replaced by the neomycin resistance gene, and the reading frame of the modified gene is disrupted. Calmodulin binds tightly to iNOS and is required for electron transfer from NADPH to the iron heme group (37, 38) .
electroporation, and clones resistant to both G418 and ganciclovir were isolated and screened by PCR using primers a and b (Fig. 1 ), which amplify a 1.6-kb product only after homologous recombination. Clones positive by PCR were confirmed by Southern analysis of BamHI-digested genomic DNA. Of 108 doubly-resistant clones screened, 6 contained the desired mutation.
Generation of iNOS -/-Mice. Two targeted ES clones, derived from independent electroporations, were microinjected into 3.5-day-old B6 blastocysts that were then implanted into pseudopregnant mice for development. Male chimeras were bred with B6 females, and offspring heterozygous for the disrupted iNOS gene were identified by Southern analysis of BamHI-digested tail DNA.
To obtain mice homozygous for the disrupted iNOS gene, the F1 B6/129 mutant heterozygotes were interbred, and their progeny were genotyped by Southern analysis. Fig. 2 shows a representative Southern blot of BamHI-digested genomic DNA; the probe hybridized to a 14-kb fragment from the wildtype allele and to a 5-kb fragment from the mutant allele. Of 266 mice genotyped, 71 (27%) were wild type (+/+), 130 (49%) were heterozygous mutant (+/-), and 65 (24%) were homozygous mutant (-/ -), which does not differ significantly from the normal Mendelian distribution (P = 0.81 by x test). The F2 mice heterozygous and homozygous for the iNOS disruption were indistinguishable from wild-type F2 mice in appearance, growth rate, reproduction, and histology. Tissues that were examined included liver, heart, aorta, lung, stomach, intestine, kidney, brain, muscle, pancreas, spleen, salivary gland, thymus, tongue, adrenal gland, and bone.
Analysis of iNOS mRNA in Macrophages from iNOS-/-Mice. The expression of iNOS mRNA in cultured peritoneal macrophages from mice of the F2 generation (Fig. 3A) was examined. Eleven hours after LPS/IFN-y treatment, total RNA was prepared and subjected to Northern analysis with two different murine iNOS-specific probes. Both the cDNA and CALM probes hybridized to a single transcript in iNOS + / + and + / -macrophages. No transcript was detected with the CALM probe in iNOS -/-macrophages. Low levels of two abnormal transcripts were detected with the cDNA probe in iNOS -/-macrophages: one transcript was slightly smaller (-4 kb), and one was significantly larger (=5.1 kb) than the 4.4-kb iNOS transcript detected in iNOS +1+ and +/-macrophages. Both abnormal transcripts also hybridized to a neomycin probe (data not shown). These observations confirm that the calmodulin-binding domain was targeted and indicate 14 that the transcripts detected in iNOS -/ -macrophages include sequences from both the iNOS and neomycin resistance genes.
Absence of iNOS Protein in Macrophages from iNOS-/-Mice. Peritoneal macrophages from thioglycollate-treated mice were cultured. Eleven hours after treatment with LPS/ IFN-,y, culture supernatants were assayed for nitrite, a stable oxidation product of NO indicative of iNOS activity. The level of nitrite was 70 ,uM in the culture medium of macrophages from iNOS +/+ mice, 36 ,uM for +/-macrophages, and <1 ,uM for -/-macrophages (medium control was < 1 ,uM). All cultures contained approximately equal numbers of cells.
In a more sensitive method for measuring NOS activity, the conversion of 14C-labeled L-arginine to citrulline was determined in lysates of LPS/IFN-,y-treated macrophages. The NOS activity was 950 pmol/min per mg of protein in iNOS +/+ macrophages, 590 in +/-macrophages, and 60 in -/-macrophages. The activity detected in macrophages from iNOS +/+ and +/-mice was inhibited >80% by 50 ,uM NG-methyl-L-arginine, a specific inhibitor of NOS, but not by 1 mM EGTA or 50 MuM trifluoperazine (a calmodulin antagonist). The low level of activity detected in macrophages from iNOS -/-mice was not inhibited by NG-methyl-L-arginine, EGTA, or trifluoperazine. Taken together, these results show that the slight activity detected in macrophages from iNOS -/-mice was not due to iNOS, or a constitutive isoform of NOS; it may be due to arginase or some other arginine or citrulline metabolizing enzyme. A similar level of activity was detected in macrophages from iNOS +/ + mice that were not treated with LPS/IFN--y (data not shown).
To confirm the absence of iNOS protein, immunoblot analysis was done on lysates of LPS/IFN-,y-treated macrophages using a polyclonal antibody to murine iNOS (Fig. 3B) . Lysates from iNOS +/+ and +/-macrophages contained the same 130-kDa immunoreactive protein that was induced in RAW 264.7 cells, a murine macrophage cell line that expresses iNOS after LPS/IFN--y treatment (7) . In contrast, lysates from iNOS -/-macrophages contained no detectable iNOS by immunoblot analysis.
LPS-Induced Shock in iNOS --Mice. Generation of NO by iNOS has been thought to play an important role in the pathogenesis of septic shock (22, 39, 40) . To evaluate the effects of iNOS deficiency on survival in an LPS-induced model for septic shock, mice were treated i.p. with LPS at either 12.5 or 25 mg/kg, and mortality was monitored over a 96-hr period. The higher dose of LPS was chosen because preliminary tests showed that it led to a mortality rate of >90% in wild-type B6 and in B6/129 F1 iNOS +/+ mice. The lower dose was chosen to allow the assessment of the effects of iNOS genotype when more wild-type survivors would be expected. F2 mice of the three iNOS genotypes (+/+, +/-, and -/-) were tested at both doses. Wild-type B6 mice were also tested at the high dose.
The results of these experiments are shown in Fig. 4 . Each experiment contained equal numbers of mice of each genotype. There were no deaths in saline-treated wild-type B6 mice. Enhanced formation of NO by iNOS in the vasculature has been implicated in the pathophysiology of septic shock. Evidence for this has come from observations that serum levels of NO oxidation products (NO,) are elevated in animals and humans undergoing septic shock (39, 44, 45) and from in vivo studies with NOS inhibitors (46, 47) . However, inhibition of NOS in rodent models for sepsis has produced conflicting results: protective (22, 40) , nonprotective (48) , and even detrimental effects (49, 50) . These studies are complicated by the fact that most of them used a nonselective NOS inhibitor. Therefore concomitant inhibition of either or both of the constitutive isozymes of NOS may have mitigated the effects of iNOS inhibition. We have avoided this complication by generating mice that lack iNOS as a consequence of targeted disruption of the iNOS gene. Our results show that F2 iNOS -/-mice are not resistant to LPS-induced mortality despite their essential lack of serum NO, elevations. Likewise, our F1 iNOS +/+ and +/-animals, which are genetically identical except for the iNOS gene disruption, were both sensitive to LPS. This result is despite the fact that the +/-animals have =50% of the normal level of iNOS activity and =50% of the serum NO. levels of wild-type animals after LPS treatment.
Experiments similar to ours have recently been reported by two other groups (42, 43) . MacMicking et al. (42) (43) found that iNOS deficiency completely prevented death after treatment with LPS at 12.5 mg/kg. In contrast, both MacMicking et al. and we observed significant mortality in iNOS -/-mice at a similar LPS dose.
The discrepancies in the data that have just been described are likely to have complex causes. The genetic backgrounds of the mutant mice and the corresponding control mice used in the three studies differed, and, in general, mouse strains differ in their sensitivities to LPS (51) . We used F1 B6/129 (+/+ and -/-) and F2 B6/129 (+/+, +/-and -/-) mice that were genetically equivalent to littermates in our comparisons. Mac 
